Ankara University Faculty of Medicine
Ankara, 06590, Turkey (Türkiye)
Location contact
Satı Coşkun Yazgan, M.D.
CONTACT
Yüksel Ürün, M.D.
CONTACT
NCT Number: NCT07096596
The PROSPEX (PROstate cancer Study of Patient EXperiences) survey is designed to systematically assess the lived experiences, challenges, and unmet needs of individuals diagnosed with prostate cancer. This observational study will collect patient-reported data on psychological, social, and practical aspects of living with prostate cancer, including the impact on quality of life and access to care. The findings aim to inform the development of patient-centered interventions and improve supportive care strategies in future clinical trials and routine practice.
Trial opening soon.
Get Notified18 year and older
Male
Observational
Ankara, 06590, Turkey (Türkiye)
Satı Coşkun Yazgan, M.D.
CONTACT
Yüksel Ürün, M.D.
CONTACT
Prostate cancer is one of the most common cancers among men worldwide, and its impact extends far beyond medical treatment, affecting many aspects of patients' lives. The PROSPEX (PROstate cancer Study of Patient EXperiences) project is designed to systematically capture the real-world experiences, challenges, and needs of individuals living with prostate cancer across diverse healthcare settings and backgrounds.
Objectives
The primary objectives of the PROSPEX study are:
Methods
The PROSPEX survey is an international, anonymous, online questionnaire designed for patients who have been diagnosed with prostate cancer. The survey includes between 70 and 125 questions, depending on each participant's disease stage and treatment history. It covers a wide range of topics, including demographic and clinical information, emotional well-being, social support, financial concerns, experiences with the healthcare system, and the impact of prostate cancer on daily life. The survey is expected to take approximately 30 to 60 minutes to complete. Participation is entirely voluntary, and no sensitive personal data or contact information will be collected or used. The study is investigator-initiated and receives no external funding; the research team declares no conflicts of interest.
Data Analysis Plan
Survey responses will be analyzed using both descriptive and inferential statistical methods. Comparative analyses will be conducted to identify variations in patient experiences across different regions, healthcare systems, and demographic groups. Advanced statistical techniques, such as regression analysis, may be used to explore factors associated with differences in quality of life, access to care, and patient outcomes.
Expected Impact
By systematically documenting the lived experiences of prostate cancer patients worldwide, the PROSPEX project aims to provide valuable insights into the challenges and unmet needs faced by this population. The findings are expected to inform healthcare providers, policymakers, and advocacy groups, guiding the development of more effective, patient-centered care and support services. Ultimately, PROSPEX seeks to improve the quality of life and care outcomes for individuals living with prostate cancer and to contribute to the global understanding of patient experiences in this disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adults (aged 18 years or older). Diagnosed with prostate cancer at any stage (localized, locally advanced, metastatic, or recurrent).
Able to understand and provide informed consent for participation. Willing and able to complete the online survey in the available languages. Access to the internet and a device to complete the survey.
Exclusion criteria
Individuals who have not been diagnosed with prostate cancer. Individuals under 18 years of age. Inability to provide informed consent. Inability to complete the survey due to cognitive, language, or technical barriers.
No Intervention: Observational Cohort
Time frame: One month
Comparative analyses will be performed using survey data to identify and quantify differences in patient experiences, quality of life, and unmet needs across various regions and healthcare settings. Results will be reported as percentages of respondents, with thorough evaluation of territorial, institutional, and socioeconomic differences. Participants will be categorized according to the World Bank's income classification: low- and lower-middle-income countries, upper-middle-income countries, and high-income countries. Descriptive statistics will be used to compare demographic and clinical characteristics, as well as patient-reported outcomes. For categorical data, Pearson Chi-Square or Fisher's Exact test will be applied; for continuous variables, ANOVA will be used. A p-value of less than 0.05 will be considered statistically significant.
Time frame: one month
Multivariate analyses, including regression modeling, will be conducted to explore associations between demographic, clinical, and healthcare system variables and patient-reported outcomes such as emotional well-being, social support, and financial concerns.
Time frame: one month
Survey responses will be analyzed to determine differences in access to supportive services, information resources, and patient education across different regions and healthcare systems.
Contact information is provided by the study sponsor or research team.
Satı Coşkun Yazgan
CONTACT
Yüksel Ürün
CONTACT
Ankara University
Other
Understanding the Experiences and Challenges of People Living With Prostate Cancer
Acronym: PROSPEX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07574541
Adenocarcinoma, Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07730125
Breast Diseases, Breast Neoplasms
View Trial DetailsNCT07478536
Active Surveillance for Prostate Cancer, Genital Diseases
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT07635524
Genital Diseases, Genital Diseases, Male
Newport Beach, California, United States
View Trial Details